1. Osteoprotective Effects of IL-33/ST2 Link to Osteoclast Apoptosis
- Author
-
Mauro M. Teixeira, Izabella Lucas de Abreu Lima, Frederico Marianetti Soriani, Priscila Maria Colavite, Mila Fernandes Moreira Madeira, Letícia Fernanda Duffles Rodrigues, Soraia Macari, Tarcília Aparecida Silva, Sandra Y. Fukada, and Gustavo Pompermaier Garlet
- Subjects
Periodontium ,Pathology ,medicine.medical_specialty ,Osteoclasts ,Apoptosis ,Fas ligand ,Bone resorption ,Pathology and Forensic Medicine ,Bone remodeling ,Weight-Bearing ,Osteoclast ,Bone Density ,Bone cell ,medicine ,Animals ,Bone Resorption ,Cells, Cultured ,Mice, Knockout ,Mice, Inbred BALB C ,Chemistry ,Osteoblast ,Cell Differentiation ,OSTEOCLASTO ,Receptors, Interleukin ,Fas receptor ,Interleukin-33 ,Interleukin-1 Receptor-Like 1 Protein ,Cell biology ,medicine.anatomical_structure ,Bone marrow ,Bone Remodeling ,Stress, Mechanical ,Biomarkers - Abstract
The relevance of IL-33 and its receptor ST2 for bone remodeling is not well-defined. Our aim was to assess the role and underlying mechanisms of IL-33/ST2 in mechanically induced bone remodeling. BALB/c (wild type) and ST2 deficient (St2(-/-)) mice were subjected to mechanical loading in alveolar bone. Microtomography, histology, and real-time quantitative PCR were performed to analyze bone parameters, apoptosis and bone cell counts, and expression of bone remodeling markers, respectively. MC3T3-E1 osteoblastic cells and bone marrow cells were used to verify if mechanical force triggered IL-33 and ST2 expression as well as the effects of IL-33 on osteoclast differentiation and activity. Mechanical loading increased the expression of IL-33 and ST2 in alveolar bone in vivo and in osteoblastic cells in vitro. St2(-/-) mice had increased mechanical loading-induced bone resorption, number of osteoclasts, and expression of proresorptive markers. In contrast, St2(-/-) mice exhibited reduced numbers of osteoblasts and apoptotic cells in periodontium and diminished expression of osteoblast signaling molecules. In vitro, IL-33 treatment inhibited osteoclast differentiation and activity even in the presence of receptor activator of NF-κB ligand. IL-33 also increased the expression of pro-apoptotic molecules, including Bcl-2-associated X protein (BAX), cell-surface Fas receptor (FAS), FASL, FAS-associated death domain, tumor necrosis factor-related apoptosis-inducing ligand, and BH3 interacting-domain death (BID). Overall, these findings suggest that IL-33/ST2 have anti-osteoclastogenic effects and reduce osteoclast formation and activity by inducing their apoptosis.
- Published
- 2015